Spyre Therapeutics (SYRE) Stock Price, Quote, News & History | Benzinga

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD83,700.57+2.40%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

Spyre Therapeutics Inc (SYRE) Stock Price, Quote, News & History

SYRENASDAQ

Trade with Public

Trade with Public

$85.90

0.210.25%

Last update: Oct 12, 5:46 PM

$86.29

0.600.7%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$86.30

Close

$85.90

Volume / Avg.

873.81K / 1.21M

Day Range

$86.29 - $86.29

52 Wk Range

18.12 - 110.18

Market Cap

$8.03B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

14.64%

Days to Cover

8.89

Recent Spyre Therapeutics Inc News

Crude Oil Edges Lower; Lamb Weston Shares Surge Following Upbeat Q1 Earnings

U.S. stocks rose Tuesday: Dow +350 points, S&P 500 +0.86%. Lamb Weston jumped 12% on strong results; Arrivent plunged 58%.

Avi Kapoor

Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.

Avi Kapoor

Spyre Therapeutics Says Rheumatoid Arthritis Program Misses Internal Benchmark, Stock Tumbles

Spyre Therapeutics shared Phase 2 SKYWAY trial data for SPY072 in rheumatoid arthritis. The therapy missed internal priority benchmarks.

Vandana Singh

Intuit, Zoom, Qfin Holdings And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures mixed, Intuit shares dip 11.7% after reporting Q4 revenue of $4.35B and adjusted earnings of $4.03/share. FY27 guidance below estimates. Other stocks moving lower in pre-market trading.

Avi Kapoor

Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares rise 3.6% in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-208.94M

Investing Cash Flow (TTM)

-463.74M

Financing Cash Flow (TTM)

753.03M

Free Cash Flow (TTM)

-208.94M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

80.35M

Analyst Trends and Forecast

3

Jun

1

Jul

7

Aug

2

Sep

3

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.01B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

8.41

Earnings Yield % (TTM)

-2.23%

Earnings Yield % (FWD)

-4.95%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$10.22

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$162.01M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-